Close Menu

Gates Foundation

The United States President's Emergency Plan for AIDS Relief, or PEPFAR, this week announced it would provide $11 million in funding for as many as 150 Cepheid GeneXpert systems and 450,000 MTB/RIF test cartridges in 14 high-burden countries in sub-Saharan Africa and Burma.

NEW YORK (GenomeWeb News) – Cornell University has raked in $25.2 million in funding from the Bill and Melinda Gates Foundation and the Department for International Development of the United Kingdom to lead an international team using genomic selection to improve cassava productivity, Cornell sai

NEW YORK (GenomeWeb News) – Partners in the UK, the US, and India have pooled together £16 million ($25.5 million) to back a number of international projects that seek to use genomic and genetic research efforts, engineering, and field trials to increase the yield in important crop plants that se

NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

NEW YORK (GenomeWeb News) – BGI and the Bill & Melinda Gates Foundation have inked a memorandum of understanding to collaborate on applying genomic tools to improving global health and agricultural development.

Cepheid said today that it has signed the first in a series of agreements with various government agencies and non-profit organizations to buy down the price of Cepheid's Xpert MTB/RIF test in a bid to drive widespread adoption of the assay in the developing world.

NEW YORK (GenomeWeb News) – Cepheid announced the first agreement to buy down the price of the Xpert MTB/RIF test in order to drive adoption of the technology in resource-poor areas of the world with multi-drug-resistant tuberculosis.

Researchers from the US Centers for Disease Control and Prevention this month published a study validating a multiplexed real-time PCR assay panel manufactured by Luxembourgian molecular diagnostics firm Fast-track Diagnostics.

Global non-profit health advocacy organization Unitaid said today that its board has approved $30 million in funding to increase access to Cepheid's Xpert MTB/RIF diagnostic test for multi-drug-resistant tuberculosis in resource-poor areas of the world.

NEW YORK (GenomeWeb News) – Global non-profit health advocacy organization Unitaid said today that its board has approved $30 million in funding to increase access to Cepheid's Xpert MTB/RIF diagnostic test for multi-drug-resistant tuberculosis in resource-poor areas of the world.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.